Latest California Healthline Stories
Voters Rejected an Anti-Abortion Measure. State GOP Lawmakers Passed a Similar Bill Anyway.
The new Montana law contains a couple of significant differences from the measure voters rebuffed last fall.
Promising Better, Cheaper Care, Kaiser Permanente’s National Expansion Faces Wide Skepticism
Kaiser Permanente, the California-based health care giant, is looking to dramatically expand its national presence. It’s committed $5 billion to a new unit called Risant Health and has agreed to acquire Pennsylvania-based Geisinger, but skeptics wonder how it will export its unique model to other states.
Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
What One Lending Company’s Hospital Contracts Reveal About Financing Patient Debt
Within two years of North Carolina’s public university system going into business with AccessOne to finance patients’ payment plans, nearly half of its patients were in loans that charged interest. As federal scrutiny increases on lenders, California Healthline is sharing that contract and others obtained through public records requests.
Amid Lack of Accountability for Bias in Maternity Care, a California Family Seeks Justice
April Valentine’s family wants to know whether racism could have played a role in her death. A California Healthline analysis shows state regulators are ill-equipped to find discrimination in its many forms.
As a Union Pushes to Cap Hospital CEO Pay, It’s Accused of Playing Politics
A union is asking Los Angeles city voters to cap hospital executive pay at the U.S. president’s salary. However, hospitals accuse the union of using the proposal as political leverage, and policy experts question whether the policy, if enacted, would be workable.
Survey: Americans Want Weight Loss Drugs Despite High Cost
A new poll reveals enthusiasm for a pricey new generation of weight loss drugs, but interest drops if users potentially have to deal with weekly injections, lack of insurance coverage, or a need to continue the medications indefinitely to avoid regaining weight.
‘Conscience’ Bills Let Medical Providers Opt Out of Providing a Wide Range of Care
Opponents of the wave of state legislation say the measures place health providers’ preferences over patients’ rights.
Doctors Sound Alarm About Child Nicotine Poisoning as Vapes Flood the US Market
Popular e-cigarettes lack packaging that stops kids from consuming the hazardous nicotine inside.
The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer’s, experts say.